Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys. 1982

J P McGovren, and J C Stewart, and G L Elfring, and R B Smith, and N Soares, and J H Wood, and D G Poplack, and D D Von Hoff

Acivicin was administered iv to rhesus monkeys bearing Ommaya reservoirs, and serial blood and cerebrospinal fluid (CSF) samples were collected and analyzed to determine the time course of drug concentrations in these body fluids. After iv doses of 4 or 20 mg/kg (50 or 250 mg/m2), acivicin plasma concentrations demonstrated a rapid initial decline (distribution phase), and then declined exponentially with a terminal (elimination phase) half-life of 3--4 hrs. CSF concentrations increased over a period of 2--2.5 hrs, reaching peak values of 2.0--2.7 micrograms/ml at 20 mg/kg and 0.3--0.5 microgram/ml at 4 mg/kg; thereafter, CSF levels declined in parallel with plasma, with a CSF/plasma concentration ratio of 0.10--0.17. A three-compartment pharmacokinetic model gave a close fit of predicted and observed plasma and CSF concentration data. Significant and predictable CSF penetration by iv administered acivicin in monkeys is consistent with observation of CNS side effects in patients in the phase I clinical trial and suggests that acivicin should be evaluated in the treatment of CNS malignancies and metastases.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J P McGovren, and J C Stewart, and G L Elfring, and R B Smith, and N Soares, and J H Wood, and D G Poplack, and D D Von Hoff
May 1985, Cancer research,
J P McGovren, and J C Stewart, and G L Elfring, and R B Smith, and N Soares, and J H Wood, and D G Poplack, and D D Von Hoff
June 1995, Antimicrobial agents and chemotherapy,
J P McGovren, and J C Stewart, and G L Elfring, and R B Smith, and N Soares, and J H Wood, and D G Poplack, and D D Von Hoff
September 1987, Pain,
J P McGovren, and J C Stewart, and G L Elfring, and R B Smith, and N Soares, and J H Wood, and D G Poplack, and D D Von Hoff
February 2015, Comparative medicine,
J P McGovren, and J C Stewart, and G L Elfring, and R B Smith, and N Soares, and J H Wood, and D G Poplack, and D D Von Hoff
October 1999, Drug metabolism and disposition: the biological fate of chemicals,
J P McGovren, and J C Stewart, and G L Elfring, and R B Smith, and N Soares, and J H Wood, and D G Poplack, and D D Von Hoff
November 1981, Cancer research,
J P McGovren, and J C Stewart, and G L Elfring, and R B Smith, and N Soares, and J H Wood, and D G Poplack, and D D Von Hoff
January 1980, Journal of medical primatology,
J P McGovren, and J C Stewart, and G L Elfring, and R B Smith, and N Soares, and J H Wood, and D G Poplack, and D D Von Hoff
May 1990, Annals of neurology,
J P McGovren, and J C Stewart, and G L Elfring, and R B Smith, and N Soares, and J H Wood, and D G Poplack, and D D Von Hoff
January 1992, Hormone research,
J P McGovren, and J C Stewart, and G L Elfring, and R B Smith, and N Soares, and J H Wood, and D G Poplack, and D D Von Hoff
January 1985, Psychopharmacology,
Copied contents to your clipboard!